Orthofix Int'l (OFIX) Misses Q1 EPS by 2c, Beat on Revenues; Raises FY17 Revenue Guidance
Get Alerts OFIX Hot Sheet
Price: $9.15 -1.51%
Revenue Growth %: +3.6%
Financial Fact:
Research and development: 6.86M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +3.6%
Financial Fact:
Research and development: 6.86M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Orthofix Int'l (NASDAQ: OFIX) reported Q1 EPS of $0.27, $0.02 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $102.7 million versus the consensus estimate of $97.17 million.
GUIDANCE:
Orthofix Int'l sees FY2017 EPS of $1.48-$1.58, versus the consensus of $1.52. Orthofix Int'l sees FY2017 revenue of $411-415 million, versus the consensus of $409.41 million.
For earnings history and earnings-related data on Orthofix Int'l (OFIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- HSBC Raises S&P500 Target to 8,100
- ABM Industries (ABM) Reports In-Line Q3 EPS; raises guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share